:
The stem cell exchange during pregnancy is thought to remain chimeras for life. Few studies
recently revealed that maternal transfer of viable stem cells to the offspring continues even after birth
during breastfeeding. Some of these stem cells are likely to be integrated into different organs (brain,
blood, kidneys, and pancreas) including neurons and insulin-producing cells in the pancreas to become
functional cells. This finding opens a new avenue for research on therapeutic uses of breast milk- derived
stem cells.
:
Recently Dr. Foteini Hassiotou used glowing mice, which were genetically modified to express a gene
called tdTomato that causes cells to appear red under fluorescence light. These mice were mated, and
their babies were swapped with the pups of another, unmodified mother mouse. The new pups suckled
the modified mouse and, as a result, obtained glowing red stem cells from breast milk. The study has
never been replicated in humans, so it is not clear yet if the findings apply to humans as in the case of
mice. However, the results of the study are the jumping-off points for future research on human breast
milk stem cells and their possible application in stem cell therapies. Additional studies are necessary to
understand the passage of human breast milk stem cells through the neonate’s GI tract, and passage to
the systemic circulation.